Jeanne Loring, Ph.D.

Jeanne Loring's Research Focus

Dr. Loring's current research focuses on the molecular basis of pluripotence and differentiation of human embryonic stem cells. Her laboratory studies human embryonic stem cells using gene expression profiling, SNP genotyping, DNA methylation and other high information content approaches to understand how pluripotence is maintained, and how to direct differentiation along specific pathways. 

Jeanne Loring's Bio

Dr. Jeanne Loring has a B.S. in Molecular Biology and a Ph.D. in Developmental Neurobiology. She was on the faculty of the University of California at Davis, and has held research and management positions at biotechnology companies, including Hana Biologics, GenPharm International, Incyte Genomics, and Arcos BioScience. She joined the faculty of Sanford-Burnham Medical Research Institute as a principal investigator in January 2004 and served as Director of the Human Stem Cell Resource and the NIH Human Embryonic Stem Cell Training Course and Co-Director of the institute's NIH Exploratory Center for Human Embryonic Stem Cell Research. In 2007, Dr. Loring joined The Scripps Research Institute as Professor of Developmental Neurobiology. 

Human Genetics Accessory


Human embryonic stem cells have a unique epigenetic signature.

Bibikova M, Chudin E, Wu B, Zhou L, Garcia EW, Liu Y, Shin S, Plaia TW, Auerbach JM, Arking DE, Gonzalez R, Crook J, Davidson B, Schulz TC, Robins A, Khanna A, Sartipy P, Hyllner J, Vanguri P, Savant-Bhonsale S, Smith AK, Chakravarti A, Maitra A, Rao M, Barker DL, Loring JF, Fan JB

Genome Res 2006 Sep ;16(9):1075-83

Transcriptome coexpression map of human embryonic stem cells.

Li H, Liu Y, Shin S, Sun Y, Loring JF, Mattson MP, Rao MS, Zhan M

BMC Genomics 2006 May 2 ;7:103

Science and law. Intellectual property and human embryonic stem cell research.

Loring JF, Campbell C

Science 2006 Mar 24 ;311(5768):1716-7

Show All Select Publications

Reducing <i>Mcl-1</i> gene dosage induces dopaminergic neuronal loss and motor impairments in <i>Park2</i> knockout mice.

Ekholm-Reed S, Baker R, Campos AR, Stouffer D, Henze M, Wolf DA, Loring JF, Thomas EA, Reed SI

Commun Biol 2019 ;2:125

Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards.

French A, Bravery C, Smith J, Chandra A, Archibald P, Gold JD, Artzi N, Kim HW, Barker RW, Meissner A, Wu JC, Knowles JC, Williams D, García-Cardeña G, Sipp D, Oh S, Loring JF, Rao MS, Reeve B, Wall I, Carr AJ, Bure K, Stacey G, Karp JM, Snyder EY, Brindley DA

Stem Cells Transl Med 2015 Mar ;4(3):217-23

Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins.

Mueller FJ, Serobyan N, Schraufstatter IU, DiScipio R, Wakeman D, Loring JF, Snyder EY, Khaldoyanidi SK

Stem Cells 2006 Nov ;24(11):2367-72

Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells.

Katkov II, Kim MS, Bajpai R, Altman YS, Mercola M, Loring JF, Terskikh AV, Snyder EY, Levine F

Cryobiology 2006 Oct ;53(2):194-205

Science and law. Intellectual property and human embryonic stem cell research.

Loring JF, Campbell C

Science 2006 Mar 24 ;311(5768):1716-7

Beyond fraud--stem-cell research continues.

Snyder EY, Loring JF

N Engl J Med 2006 Jan 26 ;354(4):321-4

Show All Publications